Panaxia Labs Israel Ltd
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company offers pharma-grade smokeless cannabis products, such as oral and sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches. Panaxia Pharmaceutical Industries Ltd has strategic partnerships with Ultra Health,… Read more
Panaxia Labs Israel Ltd (HROD) - Net Assets
Latest net assets as of June 2019: ILA-20.53 Million ILA
Based on the latest financial reports, Panaxia Labs Israel Ltd (HROD) has net assets worth ILA-20.53 Million ILA as of June 2019.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA11.33 Million) and total liabilities (ILA31.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA-20.53 Million |
| % of Total Assets | -181.24% |
| Annual Growth Rate | -12.79% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 26.97 |
Panaxia Labs Israel Ltd - Net Assets Trend (2015–2018)
This chart illustrates how Panaxia Labs Israel Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Panaxia Labs Israel Ltd (2015–2018)
The table below shows the annual net assets of Panaxia Labs Israel Ltd from 2015 to 2018.
| Year | Net Assets | Change |
|---|---|---|
| 2018-12-31 | ILA11.66 Million | +28.88% |
| 2017-12-31 | ILA9.04 Million | -29.99% |
| 2016-12-31 | ILA12.92 Million | -26.50% |
| 2015-12-31 | ILA17.57 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Panaxia Labs Israel Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 502600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2018)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA13.97 Million | 81.89% |
| Other Components | ILA92.92 Million | 544.77% |
| Total Equity | ILA17.06 Million | 100.00% |
Panaxia Labs Israel Ltd Competitors by Market Cap
The table below lists competitors of Panaxia Labs Israel Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hub Cyber Security Ltd. Warrant 8/22/23
NASDAQ:HUBCZ
|
$112.85K |
|
Fundo De Investimento Nas Cadeias Produtivas Agroindustriais Jgp Credito Fiagro Imobiliario
SA:JGPX11
|
$113.19K |
|
AVALA RES
F:CVJ
|
$113.22K |
|
Constellation Oil Services Holding S.A.
OL:COSH
|
$113.31K |
|
FNSTech Co. Ltd.
KO:083500
|
$112.78K |
|
Castle Peak Mining Ltd
PINK:CPKOF
|
$112.73K |
|
LORDS CO. WORLDW. HOLD.
F:4XM
|
$112.71K |
|
Sydinvest Verden Ligevægt & Value KL
CO:SYIVLVADKK
|
$112.68K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Panaxia Labs Israel Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2017 to 2018, total equity changed from 13,935,000 to 17,057,000, a change of 3,122,000 (22.4%).
- Net income of 2,732,000 contributed positively to equity growth.
- Other factors increased equity by 390,000.
Equity Change Factors (2017 to 2018)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA2.73 Million | +16.02% |
| Other Changes | ILA390.00K | +2.29% |
| Total Change | ILA- | 22.40% |
Book Value vs Market Value Analysis
This analysis compares Panaxia Labs Israel Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Panaxia Labs Israel Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.02%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.06x
- Recent ROE (16.02%) is above the historical average (-14.68%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -24.60% | 0.00% | 0.00x | 1.54x | ILA-7.73 Million |
| 2016 | -29.29% | 0.00% | 0.00x | 1.69x | ILA-6.88 Million |
| 2017 | -20.85% | 0.00% | 0.00x | 1.93x | ILA-4.30 Million |
| 2018 | 16.02% | 0.00% | 0.00x | 1.06x | ILA1.03 Million |
Industry Comparison
This section compares Panaxia Labs Israel Ltd's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $38,238,889
- Average return on equity (ROE) among peers: -24.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Panaxia Labs Israel Ltd (HROD) | ILA-20.53 Million | -24.60% | N/A | $112.83K |
| Biomedix Incubator Ltd (BMDX) | $22.00 Million | -65.28% | 0.03x | $127.40K |
| Black Sea Property PLC Ordinary Shares (BSP) | $1.91 Million | -202.26% | 1.13x | $59.37K |
| Ai Conversation Systems Ltd (FVT) | $22.19 Million | 66.99% | 2.97x | $8.00K |
| Gamatronic Electronic Industries Ltd (GAMT) | $108.08 Million | 0.13% | 0.24x | $38.38K |
| The Israel Land Development Company Ltd (ILDA) | $21.85 Million | -30.46% | 0.50x | $30.98K |
| Insuline Medical Ltd (INSL) | $-2.26 Million | 0.00% | 0.00x | $7.11K |
| Itay Financial A.A Investments Ltd (ITYF) | $20.94 Million | 32.06% | 24.49x | $10.58K |
| Micronet Ltd (MCRNL) | $62.64 Million | -1.68% | 0.65x | $13.95K |
| Netz Hotels Ltd (NZHT) | $86.81 Million | -22.84% | 0.00x | $1.52K |